Showing 111-120 of 2128 results for "".
Scientifically Speaking: The Truth About Skincare
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-the-truth-about-skincare/19876/From workhorse ingredients like antioxidants and retinol to newer molecules that address pigmentation and aging, there is a lot of noise in the skincare marketplace. And that's without talking about "natural" formulations. Joel L. Cohen, MD gets to the heart of the science, in a conversation with DeHilary Baldwin, MD: Perspective on the FDA Citizen's Petition for Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/hilary-baldwin-md-perspective-fda-citizens-petition-acne-products-benzoyl-peroxide-bpo/24171/Neal Bhatia, MD, chief medical editor of Practical Dermatology® talks to Hilary E. Baldwin, MD about a new report from an independent laboratory that finds benzene can form at unacceptably high levels in both over-the-counter and prescription medications that contain benzoyl peroxide.AK Burden and Progression Risk
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-burden-and-progression-risk/20134/Individuals with chronic sun damage are at higher risk of developing AK lesions. It is therefore essential that dermatologists emphasize early sun protection recommendations and address progression risks of AK with their patients. Faced with increasing burden of skin cancers, Joel L. Cohen, MD and AScientifically Speaking: Applying Energy-Based Devices Across Skin Tones
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-applying-energy-based-devices-across-skin-tones/19895/With advancements in technology and a patient-focused approach to treatment, it's possible to safely and effectively apply energy-based devices to a range of skin concerns in patients with darker skin. Host Joel L. Cohen, MD discusses treatment strategies for melasma, acne, PFB, scarring and more wiThe Gist of the JECK
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-gist-of-the-jeck/19727/Ava Shamban, MD talks to Joel Cohen, MD about the JECK (where the jawline blends into the neck), and the combination approach she has developed to improve the appearance of this area.Atopic Dermatitis Guidelines Update
https://practicaldermatology.com/topics/general-topics/atopic-dermatitis-guidelines-update/18949/Peter Lio, MD speaks with Joel Cohen, MD about atopic dermatitis consensus recommendations, particularly the differences among different medical specialties. He also discusses how global guidelines may begin to take shape.Pigmentation Disorders
https://practicaldermatology.com/topics/pigmentary-disorders/pigmentation-disorders/19730/Sunscreen may be the first, second, and third thing recommended for patients with pigmentation disorders, but what comes next? Joel Cohen, MD interviews Amit Pandya, MD to learn about treatment options and developments in the pipeline.Aloha Maui Derm
https://practicaldermatology.com/topics/psoriasis/aloha-maui-derm/19715/What is the magic that makes Maui Derm so special? Joel Cohen, MD and meeting founder and director George Martin, MD, go behind the scenes of one of the most popular meetings in dermatology.Estrogen and Skin: What Can We Do
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/estrogen-and-skin-what-can-we-do/20123/There’s accumulated evidence that depletion of estrogen with age contributes to the visible signs of skin aging. But dermatologists haven’t had many treatment options—until now. Joel L. Cohen, MD addresses the latest developments in care for estrogen deficient skin.Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, Re